Corcept Therapeutics Incorporated (CORT) Balance Sheet: Assets & Liabilities

Corcept Therapeutics Incorporated (CORT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Corcept Therapeutics Incorporated reported total assets of $836.65M and total liabilities of $188.85M. Shareholders' equity was $647.80M, down 4.7% from $679.59M a year earlier. Total debt stood at $6.11M against $372.15M in cash and short-term investments, a net cash position of $366.05M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Corcept Therapeutics Incorporated Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Corcept Therapeutics Incorporated (CORT) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	120.50	127.67	135.55	66.33	77.62	76.19	31.27	206.76	104.03
Short-Term Investments	251.66	255.67	232.67	365.34	145.92	364.51	244.69	0.00	0.00
Cash & Short-Term Investments	372.15	383.33	368.22	431.67	223.54	440.70	275.96	206.76	104.03
Accounts Receivable	59.79	58.08	41.12	31.06	27.63	27.50	19.93	17.59	28.20
Inventory	12.87	12.41	7.73	6.10	4.99	4.91	5.42	16.24	8.38
Other Current Assets	40.66	17.78	27.56	16.42	10.32	5.40	6.04	7.74	2.67
Total Current Assets	485.46	471.60	458.64	499.25	266.46	478.50	307.36	240.59	140.60
Non-Current Assets
Property, Plant & Equipment (Net)	6.47	8.01	0.32	1.78	1.52	4.18	4.50	0.66	0.52
Long-Term Investments	160.27	219.83	57.18	4.95	112.28	36.20	39.35	0.00	15.28
Other Non-Current Assets	184.44	10.19	105.39	15.99	43.50	21.25	15.43	7.79	3.24
Total Non-Current Assets	351.19	368.95	162.88	84.18	157.29	93.23	104.95	71.10	79.94
Total Assets	836.65	840.55	621.52	583.43	423.76	571.73	412.31	311.69	220.54
Current Liabilities
Accounts Payable	40.44	15.38	17.40	11.98	6.91	10.55	7.54	8.27	8.58
Short-Term Debt	1.08	0.83	0.15	1.14	0.53	2.05	1.56	0.00	0.00
Accrued Liabilities	124.56	37.21	86.96	31.91	40.11	34.69	-	-	-
Deferred Revenue	35.68	0.00	18.47	11.10	11.17	0.00	0.00	0.00	0.00
Other Current Liabilities	73.70	124.38	14.65	0.76	0.30	0.20	29.27	25.77	20.99
Total Current Liabilities	166.09	140.77	104.51	72.49	47.54	47.49	38.84	35.81	29.57
Non-Current Liabilities
Long-Term Debt	5.02	6.11	0.00	0.00	0.00	0.50	1.90	0.00	0.00
Other Non-Current Liabilities	17.74	14.08	10.31	9.10	0.41	0.40	0.39	0.24	0.00
Total Non-Current Liabilities	22.76	20.19	10.31	9.10	0.41	0.90	2.29	0.24	0.00
Total Liabilities	188.85	160.96	114.81	81.59	47.95	48.39	41.13	35.81	29.57
Stockholders' Equity
Common Stock	0.14	0.14	0.13	0.13	0.13	0.12	0.12	0.12	0.12
Retained Earnings	643.39	543.74	402.53	296.39	194.97	82.46	-23.56	-117.74	-193.15
Accumulated Other Comprehensive Income	2.26	-0.22	0.61	-0.87	-0.23	0.42	0.26	-0.07	-0.08
Treasury Stock	966.59	696.17	635.08	456.15	410.41	-	-	-	-
Additional Paid-in Capital	2.01	135.94	738.52	662.34	591.35	440.35	394.36	393.57	384.07
Shares Outstanding	105.97	105.11	103.41	107.84	105.94	-	-	-	-
Total Stockholders' Equity	647.81	679.59	506.71	501.84	375.81	523.34	371.18	275.88	190.97
Total Liabilities & Equity	836.65	840.55	621.52	583.43	423.76	571.73	412.31	311.69	220.54

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Corcept Therapeutics Incorporated Balance Sheet

How much debt does Corcept Therapeutics Incorporated have?

Corcept Therapeutics Incorporated had total debt of $6.11M as of Dec 31, 2025, against $372.15M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $6.94M a year earlier.

What are Corcept Therapeutics Incorporated's total assets?

Corcept Therapeutics Incorporated reported total assets of $836.65M as of Dec 31, 2025, down 0.5% from $840.55M a year earlier. Total liabilities were $188.85M.

What is Corcept Therapeutics Incorporated's shareholders' equity?

Corcept Therapeutics Incorporated's shareholders' equity was $647.80M as of Dec 31, 2025, or about $6.11 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition